Researchers at the University of Bradford are developing an innovative artificial intelligence (AI) system designed to significantly improve the early detection and ongoing monitoring of Parkinson’s disease. This pioneering project leverages ordinary smartphone video recordings to analyse subtle movement patterns, offering a non-invasive and accessible method for identifying the condition sooner and tracking its progression.
The initiative, led by Dr. Ramzi Jaber, a Researcher in Data Science for Applied AI at the University, aims to address the challenges associated with diagnosing Parkinson’s, which often occurs at later stages when symptoms are more pronounced. Early and accurate detection is crucial for managing the disease effectively, allowing for timely interventions that can help improve patients’ quality of life and potentially slow the advancement of symptoms.
The AI system functions by meticulously analysing movements captured through smartphone video. These analyses can identify minute changes in gait, tremor, and other motor functions that might be imperceptible to the human eye or only become obvious as the disease progresses. This approach promises to streamline the diagnostic process, making it more efficient and potentially expanding healthcare access to advanced screening tools.
By utilising readily available technology like smartphones, the research has the potential to transform how Parkinson’s is identified and monitored, particularly in remote areas or for individuals with limited mobility. The goal is for this AI-driven tool to provide an objective measure of motor symptoms, assisting clinicians in making more informed decisions and enabling personalised care plans. Such technology could also potentially integrate with digital health platforms, similar to how patients can manage appointments via the NHS App, enhancing the overall patient experience.
As the system continues through its development phase, researchers will focus on rigorous validation to ensure its accuracy and reliability. The successful implementation of such AI tools could not only accelerate early diagnoses but also provide valuable insights into disease progression, helping to refine treatments and understand how therapies impact a patient’s motor function over time. This development marks a significant step forward in harnessing technology for improved neurological health outcomes.